INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V909. A total of 2 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $72,000 | +10.8% | 15,600 | -16.1% | 0.00% | 0.0% |
Q4 2018 | $65,000 | -91.3% | 18,600 | -74.8% | 0.00% | -83.3% |
Q3 2018 | $745,000 | -23.5% | 73,900 | -45.1% | 0.01% | -25.0% |
Q2 2018 | $974,000 | -24.8% | 134,500 | -37.3% | 0.01% | -38.5% |
Q1 2018 | $1,296,000 | -21.9% | 214,600 | +24.3% | 0.01% | +8.3% |
Q4 2017 | $1,660,000 | +597.5% | 172,600 | +544.0% | 0.01% | +500.0% |
Q3 2017 | $238,000 | -76.3% | 26,800 | -66.3% | 0.00% | -80.0% |
Q2 2017 | $1,006,000 | -11.5% | 79,500 | -26.5% | 0.01% | -23.1% |
Q1 2017 | $1,137,000 | +2.4% | 108,200 | -10.4% | 0.01% | +18.2% |
Q4 2016 | $1,110,000 | +360.6% | 120,700 | +491.7% | 0.01% | +266.7% |
Q3 2016 | $241,000 | +107.8% | 20,400 | +126.7% | 0.00% | +200.0% |
Q2 2016 | $116,000 | -86.5% | 9,000 | -83.2% | 0.00% | -91.7% |
Q1 2016 | $857,000 | -77.1% | 53,600 | -59.0% | 0.01% | -72.7% |
Q4 2015 | $3,742,000 | +132.7% | 130,700 | +131.3% | 0.04% | +100.0% |
Q3 2015 | $1,608,000 | -70.5% | 56,500 | -62.8% | 0.02% | -71.1% |
Q2 2015 | $5,449,000 | +4157.0% | 151,700 | +6795.5% | 0.08% | +3700.0% |
Q1 2015 | $128,000 | -75.1% | 2,200 | -82.0% | 0.00% | -75.0% |
Q4 2014 | $514,000 | +18.4% | 12,200 | +8.9% | 0.01% | +14.3% |
Q3 2014 | $434,000 | +101.9% | 11,200 | +62.3% | 0.01% | +133.3% |
Q2 2014 | $215,000 | +1164.7% | 6,900 | +1625.0% | 0.00% | – |
Q1 2014 | $17,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 120,700 | $1,110,000 | 0.01% |
SIMPLEX TRADING, LLC | 450 | $7,000 | 0.00% |